R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome

被引：5
|
作者：
Martin, Alejandro [1 ]
Caballero, Maria-Dolores [2 ]
机构：
[1] Complejo Hosp Zamora, Dept Hematol, Zamora 49022, Spain
[2] Hosp Univ Salamanca, Dept Hematol, Salamanca, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷 / 05期
关键词：
RITUXIMAB;
D O I：
10.3324/haematol.2009.006452
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：744 / 744
页数：1
相关论文
共 50 条
  • [1] Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation
    Salido Toimil, F.
    Torres Carrete, P.
    Deben Ariznavarreta, G.
    Varela Gomez, M. R.
    Lopez Fernandez, M. F.
    Noriega Concepcion, V.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S300 - S301
  • [2] R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma
    Montoro, Juan
    Andreola, Giovanna
    Gardellini, Angelo
    Babic, Aleksandra
    Negri, Mara
    Frungillo, Niccolo
    Martinelli, Giovanni
    Laszlo, Daniele
    TRANSFUSION AND APHERESIS SCIENCE, 2014, 50 (03) : 411 - 414
  • [3] R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study
    Martin, Alejandro
    Conde, Eulogio
    Arnan, Montserrat
    Canales, Miguel A.
    Deben, Guillermo
    Sancho, Juan M.
    Andreu, Rafael
    Salar, Antonio
    Garcia-Sanchez, Pedro
    Vazquez, Lourdes
    Nistal, Sara
    Requena, Maria-Jose
    Donato, Eva M.
    Gonzalez, Jos A.
    Leon, Angel
    Ruiz, Concepcion
    Grande, Carlos
    Gonzalez-Barca, Eva
    Caballero, Maria-Dolores
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1829 - 1836
  • [4] R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: Influence of prior exposure to rituximab on outcome (a gel-TAMO study)
    Martin, A.
    Conde, E.
    Arnan, M.
    Canales, M. A.
    Deben, G.
    Sancho, J. M.
    Andreu, R.
    Salar, A.
    Garcia-Sanchez, P.
    Nistal, S.
    Requena, M. J.
    Donato, E. M.
    Gonzalez, J. A.
    Leon, A.
    Ruiz, C.
    Grande, C.
    Caballero, M. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 149 - 149
  • [5] R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: A Spanish GEL-TAMO multicenter study
    Martin, Alejandro
    Conde, Eulogio
    Arnan, Montserrat
    Canales, Miguell A.
    Deben, Guillermo
    Andreu, Rafael
    Salar, Antonio
    Garcia-Sanchez, Pedro
    Nistal, Sara
    Requena, Maria J.
    Donato, Eva M.
    Gonzalez, Jose A.
    Leon, Angel
    Ruiz, Concepcion
    Grande, Carlos
    Arranz, Reyes
    Duran, Soledad
    Ortegon, Sergio
    Rodriguez, Juan N.
    Sandoval, Virgilio
    Andreu, Maria A.
    Bernal, Teresa
    Hernandez, Miguel T.
    Gonzalez-Barca, Eva
    Caballero, Maria D.
    BLOOD, 2007, 110 (11) : 1007A - 1008A
  • [6] Lenalidomide in Combination with R-ESHAP (LR-ESHAP) in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Who Are Candidates for Autologous Stem-Cell Transplantation: A Phase 2 Study from the Spanish Group Geltamo
    Martin, Alejandro
    Baile, Monica
    Rodriguez, Guillermo
    Dlouhy, Ivan
    Sancho, Juan Manuel
    Jarque, Isidro
    Gonzalez-Barca, Eva
    Salar, Antonio
    Espeso, Manuel
    Grande, Carlos
    Bergua, Juan
    Montes-Moreno, Santiago
    Lopez-Guillermo, Armando
    Caballero, Dolores
    BLOOD, 2016, 128 (22)
  • [7] R-ESHAP-LENALIDOMIDE AS SALVAGE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA CANDIDATES TO STEM-CELL TRANSPLANTATION: UPDATED RESULTS OF A PHASE IB GELTAMO STUDY
    Martin, A.
    Redondo, A. M.
    Lopez-Guillermo, A.
    Salar, A.
    Gonzalez-Barca, E.
    Canales, M.
    Caballero, D.
    HAEMATOLOGICA, 2014, 99 : 155 - 155
  • [8] Autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: influence of prior exposure to rituximab on outcomes
    Redondo, A.
    Martin, A.
    Guardado, L.
    Martin, A.
    Rojas, S.
    Gutierrez, N.
    Vidriales, B.
    Gonzales, M.
    San Miguel, J.
    Caballero, D.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S451 - S452
  • [9] Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO
    Martin Garcia-Sancho, A.
    Baile, M.
    Rodriguez, G.
    Dlouhy, I.
    Sancho, J. M.
    Jarque, I.
    Gonzalez-Barca, E.
    Salar, A.
    Espeso, M.
    Grande, C.
    Bergua, J.
    Montes-Moreno, S.
    Redondo, A.
    Enjuanes, A.
    Campo, E.
    Lopez-Guillermo, A.
    Caballero, D.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 203 (02) : 202 - 211
  • [10] Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma
    Kuruvilla, John
    Pintilie, Melania
    Tsang, Richard
    Nagy, Tracy
    Keating, Armand
    Crump, Michael
    LEUKEMIA & LYMPHOMA, 2008, 49 (07) : 1329 - 1336
12345